Welcome to our October 22 SPECIAL issue of #JACCCaseReports @JACCJournals focusing on #NYV2025 and multivalve disease submissions! https://t.co/4acX848Orp Full PDF here: https://t.co/wrAcDdkDsj @MinnowWalsh @DeeDeeWangMD @hmkyale @Justine_Turco New York Valves Acute

@JAMarbach @benhibbertMDPhD Excellent article! This article highlights a significant shift in the field of automotive management. It serves as a timely reminder that our goal should not merely be to pursue "numbers," but rather to restore meaningful tissue oxygenation and organ perfusion.

https://t.co/mJ0mLfxiQI

Advancing Cardiogenic Shock Research Dr. Sandeep Nathan (@SandeepNathanMD), Section of Cardiology at @UChicagoMed, co-authored the newly released SCAI Door to Lactate Clearance (DLC) Initiative with @SCAI. Published in JSCAI, this work highlights how lactate clearance can guide

Macrovascular perfusion targets (from MAP to CO) are a cornerstone of cardiogenic shock management. But what about the microvasculature? Read our #JACCAdvances review highlighting the emerging role of markers of peripheral and tissue perfusion in CS! https://t.co/6eSMxzqcbj

Should treatments that improve peripheral perfusion take precedence over a focus on hemodynamics in cardiogenic shock management? We explore the evolving paradigm of shock care and why it’s time to rethink what truly matters https://t.co/1WpXgJpas3 @benhibbertMDPhD

@SVRaoMD @SrihariNaiduMD It’s currently associated with better outcomes. What I worry about more is targeting the lactate doesn’t necessarily mean outcomes are better. If it becomes a target ppl might do more things to normalize the lactate that actually harm patients. Don’t think it can happen -

Special issue of @cardiacinterv just out with a sneak peak discussion of the @SCAI #DLC initiative. The full peer reviewed position statement will be out in @MyJSCAI during SCAI SHOCK Tampa! Sept 18-20 Link: https://t.co/W7ZXR3ioxs @Babar_Basir @agtruesdell @davebaran

Grateful for the opportunity to present both a research abstract and a complex TAVR case at #NYValves2025 , a conference full of learning and inspiration. Thankful for the valuable mentorship of Dr Golwala @HarshGMD, Dr. Firas Zahr and @JAMarbach along the way!🫀@OHSUCardFellows

Oof. When you forget to remove the chatGPT intro to your job post.

📅 June 27 | 1–4 PM CT | Advanced HF Virtual Summit Join @American_Heart to explore treatment and access solutions for advanced heart failure patients. Speakers from UCSD, Baptist Memorial Hospital Memphis & OHSU https://t.co/HBhPH13jBB #HFSummit #advancedHF #HeartFailure

Not too much goin' on today, so I thought I'd tell you about a new paper just published in @NEJMEvidence, w/ @metrics52, @carolxmgao, and @rwyeh We explain why instrumental variable (IV) methods are essential for randomized trials of medical interventions that fail to play out

MI deaths in cancer patients are declining but disparities remain. From 1999–2020, 100K+ deaths: • AAMR dropped from 4.01 → 1.33 • Highest risk: NH Black pts, rural areas, prostate/lung cancers • Men > Women Gains made, but equity gaps persist. #ACC25 @JAMarbach @OHSUNews

📘#SCAIMCSebook Highlight: Chapter 9 Patient Identification and Device Selection This chapter highlights tailored #MCS decisions for acute decompensated #HeartFailure and #MI. ➡️ https://t.co/Fqqcy9uIQO #ADHF #Cardiology @NavinKapur4 @JAMarbach @ChweichHaval @leahkosyakovsky

The #ShockwaveC2plus catheter has 120 IVL pulses. How do you spend yours? Hear Dr @JAMarbach from @OHSUCardio share how he used #All120 pulses to treat this heavily calcified Cx. Learn more about Shockwave C2+: https://t.co/bk6Nr0J3dC US Rx only. ISI https://t.co/sZ0NdzXNcV

New work in @CircAHA on Mixed Cardiogenic Shock. The document proposes a Standardized Classification, a Hemodynamic Definition, and Framework for Management. Below is the proposed hemodynamic definition of cardio-vasodilatory shock. A thread ..... 1/5

We clearly need more dedicated #CICU trials of #VTstorm to learn how to treat these patients. It's like early days of cardiogenic shock. With @fdanielramirez we are doing the SEDATE trial looking at Precedex up front for treatment of VT storm and have started recruiting.

The new @SCAI MCS EBook is here (download below!) I had a great time bringing together ths best of both interventional and critical care (@JAMarbach @NavinKapur4 @ChweichHaval) to write about device selection in cardiogenic shock. https://t.co/W0GtoNzp9J

Please to share our 📜under the mentorship of @JAMarbach , We explores how complete revascularization compares to culprit-only revascularization in older adults (75+) in terms of restricted mean survival time. 🔗 https://t.co/gTRf3HanJq @OHSUCardFellows

Almost a month into fellowship, we are so proud to have this amazing team of new @OHSUCardio fellows. We are really excited to keep learning with you✨🫀🤓